Joanna Glasner
The venture capital industry is full of stories lately about funds downsizing and startups seeking smaller rounds from early stage investors. But 30-year-old Institutional Venture Partners (IVP) added a new spin on the industry status quo today with the announcement that it has closed a new fund that a) is larger than its last one; […]
E-commerce marketing, electric motorcycles and chia seeds are seeing some love from investors. That, at least, is the short takeaway from poking through securities filings this morning. The search unearthed a few funding rounds for startups and one for a venture fund.
Funding recipients include the following:
--MyBuys, a provider of personalized product recommendations, has raised $2.5 million in new funding, according to a securities filing.
Six VC-backed companies priced in June, followed by three more as of mid-July
Venture capitalists have put a lot of money over the past couple of years into companies developing treatments for eye disease. Now they’re seeing some ROI.
This week, venture backers in LensX Lasers got what looks on paper to be a very nice exit that could turn into a much better one, when Alcon announced that it has entered into a definitive agreement to acquire the company. Alcon will pay US $361.5 million in cash for LenSX, a developer of a laser used in cataract treatment, plus maximum contingent payments of US $382.5 million if it hits agreed-upon milestones.
Four-year-old LenSx, which developed what Alcon says developed is first femtosecond laser to receive U.S. Food and Drug Administration clearance for use as a part of cataract surgery, previously raised $32 million in venture funding. The Aliso Viejo, Calif.-based company’s investors include InterWest Partners, SV Life Sciences Advisers and Versant Ventures.
Accel’s newest venture partner reflects on Real Networks, where his VC interests lie and what’s really important in life
Brain-related investments have yet to produce a blockbuster exit, but VCs think they’re getting close to a breakthrough
First half of year looks strong compared to same time last year, but more companies are slashing prices to get deals done
A sluggish economy usually means stagnant pay. But for CEOs of venture-funded startups, the dismal exit climate appears to be having the opposite effect.
Today, VC-backed CEOs earn more than they did 10 years ago, according to a study by the National Venture Capital Association and executive search firm Spencer Stuart.
In a survey of venture investors, researchers found that 47% of respondents said that they are paying CEOs comparably greater cash compensation and granting more equity.
The survey followed up on a previous one carried out in 2001, with findings showing that a mix of static and changing attitudes among VCs toward management teams of startups they fund.
Faced with the combination of an unwelcoming IPO market and implacably slow drug approval process, biotech startups and their backers these days are all about business models that can generate a return without waiting for FDA endorsement. So, it’s not surprising that one of the larger biotech Series A rounds in recent weeks went to […]
The managing partner of Millennium Technology Ventures discusses his firm’s latest fund, how the economy has affected the secondary market and how he spends his time when he’s not working